Clinical significance of brain natriuretic peptide in primary pulmonary hypertension
- 3 March 2004
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 43 (5), 764-770
- https://doi.org/10.1016/j.jacc.2003.09.051
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Inhaled Iloprost for Severe Pulmonary HypertensionThe New England Journal of Medicine, 2002
- Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart DiseaseCirculation, 2002
- Hemodynamic Effects of Aerosolized Iloprost in Pulmonary Hypertension at Rest and During ExerciseSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2002
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001
- Cardiac natriuretic peptides - hope or hype?Journal of Clinical Pharmacy & Therapeutics, 2001
- Brain and Atrial Natriuretic Peptides in Patients with Ischemic Heart Disease with and without Heart FailureCardiology, 1996
- Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levelsJournal of the American College of Cardiology, 1995
- Expression of Endothelin-1 in the Lungs of Patients with Pulmonary HypertensionThe New England Journal of Medicine, 1993
- An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary HypertensionThe New England Journal of Medicine, 1992
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.JCI Insight, 1991